Alcon Inc.  (ACL) Trade Now »     Rate ACL  -  Discuss ACL  -  Add to Watch List        

Expanding Defensive Growth Index into Europe

The accompanying table presents an updated version of the ETFI Highly Defensive PerformIdex, which is expanded to 40 companies with market caps of at least $10B from the industry groups listed below. This defensive growth index is heavily weighted in consumer staples and healthcare and is now structured to include companies based in Europe, in addition to the United States and Canada.

Compared to the previous version, this index has a lower beta and higher average market cap and adds European companie

"You may not have your eye on Alcon (NYSE: ACL)," notes global expert Frida Ghitis, adding, "But if you wear contact lenses, suffer from dry eyes, worry about glaucoma, or even if you have hay-fever, you may have bought its products."

Here, the contributing advisor to Vivian Lewis' Global Investing, explains, "This Swiss eye drug giant has its eyes on both the bottom line and its pipeline."

"As the world’s largest eye care company, ALC has excellent management, stellar performance, promising demographics, and an intriguing ownership structure.
 
"Demographics bode well. Aging eyes need attentio

Filed under: International markets, Newsletters, Stocks to Buy

"You may not have your eye on Alcon Inc. (NYSE: ACL), but if you wear contact lenses, suffer from dry eyes, worry about glaucoma, or even if you have hay-fever, you may have bought ACL products," notes global expert Frida Ghitis.

Here, the contributing advisor to Vivian Lewis' Global Investing, explains, "This Swiss eye drug giant has with its eyes on both the bottom line and the pipeline.

"As the world's largest eye care company, ALC has excellent management, stellar performance, promising demographics, and an intriguing ownershi